Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 12, 2016

Sandstone’s Trak Male Fertility Testing System gets FDA 510(k) clearance

US-based digital health company Sandstone Diagnostics has secured 510(k) clearance from the Food and Drug Administration (FDA) for its Trak Male fertility testing system.

US-based digital health company Sandstone Diagnostics has secured 510(k) clearance from the Food and Drug Administration (FDA) for its Trak Male fertility testing system.

The Trak in-home test allows couples to monitor sperm counts, ensuring privacy when they plan to conceive.

Sandstone CEO Greg Sommer said: "This FDA clearance represents a monumental milestone for Sandstone Diagnostics as we prepare to launch Trak as a radically new approach to personal fertility management.

"Male infertility is a dramatically under-appreciated condition affecting millions of couples every year.

"Male infertility is a dramatically under-appreciated condition affecting millions of couples every year."

"Trak is a complete system that not only gives couples the ability to conveniently measure semen quality at home, but also provides digital health tools and population-based data to help men take charge of their reproductive health in a whole new way."

The device uses a centrifugal force to classify and calculate sperm cells using specially designed disposable cartridges.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Trak Engine and several disposable test kits constitute the equipment and allow repeat testing.

The fully integrated Trak System digital health system also accompanies the Trak mobile application.

The pairing enables men to enter, track and compare their results to population statistics through the cloud-based community of users and clinical databases while receive personalised feedback on lifestyle and wellness steps that may increase their sperm count.

The company noted Trak is the first FDA-approved device to classify sperm count as low, moderate or optimal aligned with the World Health Organisation (WHO) guidelines and clinical studies that correlate higher sperm counts with faster time to pregnancy.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU